Reporting on complex health policy issues is no easy task. By supporting Tradeoffs, you help make our ambitious storytelling, relentless fact finding, and rigorous research possible.
Health economist Kosali Simon shares conference tips, stories and abstracts she's excited for at AcademyHealth and ASHEcon.
From the fear of shutting down to the exhaustion of reopening and the missed appointments in between.
The FDA weighs whether to approve a controversial new Alzheimer's drug.